{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:08:21Z","timestamp":1793833701638,"version":"4.6.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["093652"],"award-info":[{"award-number":["093652"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["020670"],"award-info":[{"award-number":["020670"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["068031"],"award-info":[{"award-number":["068031"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["066606"],"award-info":[{"award-number":["066606"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018576","name":"Harrington Discovery Institute, University Hospitals","doi-asserted-by":"publisher","award":["A25-1690"],"award-info":[{"award-number":["A25-1690"]}],"id":[{"id":"10.13039\/100018576","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The epoxyeicosatrienoic acids (EETs) are derivatives of the arachidonic acid metabolism with anti-inflammatory activities. However, their efficacy is limited due to the rapid hydrolysis by soluble epoxide hydrolase (sEH). Inhibition of sEH has been shown to stabilize the EETs and reduce neuroinflammation in A\u03b2 mouse models of Alzheimer\u2019s disease (AD). However, the role of the sEH-EET signaling pathway in other CNS cell types and neurodegenerative conditions are less understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Here we investigated the mechanisms and functional role of the sEH-EET axis in tauopathy by treating PS19 mice with a small molecule sEH inhibitor TPPU and by crossing the PS19 mice with\n                      <jats:italic>Ephx2<\/jats:italic>\n                      (gene encoding sEH) knockout mice. This was followed by single-nucleus RNA-sequencing (snRNA-seq), biochemical and immunohistochemical analysis, and behavioral assessments. Additionally, we examined the effects of the sEH-EET pathway in primary microglia cultures and human induced pluripotent stem cell (iPSC)-derived neurons exhibiting seeding-induced Tau inclusions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>sEH inhibition improved cognitive function, rescued neuronal cell loss, and reduced Tau pathology and microglial reactivity. snRNA-seq revealed that TPPU treatment upregulated genes involved in actin cytoskeleton and excitatory synaptic pathways. Treatment of human iPSC-derived neurons with TPPU enhanced synaptic density without affecting Tau accumulation, suggesting a cell-autonomous neuroprotective effect of sEH blockade. Furthermore, sEH inhibition reversed disease-associated and interferon-responsive microglial states in PS19 mice, while EET supplementation promoted Tau phagocytosis and clearance in primary microglia cultures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings demonstrate that sEH blockade or EET augmentation confers therapeutic benefit in neurodegenerative tauopathies by simultaneously targeting neuronal and microglial pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-025-00844-x","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T21:18:38Z","timestamp":1745356718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model"],"prefix":"10.1186","volume":"20","author":[{"given":"Shuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangye","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Rajpurohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baijayanti","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5427-3798","authenticated-orcid":false,"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"2","key":"844_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312\u201339.","journal-title":"Cell"},{"issue":"1","key":"844_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-023-00656-x","volume":"18","author":"S Gandy","year":"2023","unstructured":"Gandy S. News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer\u2019s disease in 2023. Mol Neurodegener. 2023;18(1):66.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"844_CR3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/brain\/awad005","volume":"146","author":"R Perneczky","year":"2023","unstructured":"Perneczky R, et al. Anti-amyloid antibody therapies in Alzheimer\u2019s disease. Brain. 2023;146(3):842\u20139.","journal-title":"Brain"},{"issue":"9","key":"844_CR4","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology. 2003;60(9):1495\u2013500.","journal-title":"Neurology"},{"issue":"1","key":"844_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs GG. Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol. 2015;41(1):3\u201323.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"844_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Tauopathies: new perspectives and challenges. Mol Neurodegener. 2022;17(1):28.","journal-title":"Mol Neurodegener"},{"key":"844_CR7","doi-asserted-by":"crossref","unstructured":"Chang CW, Shao E, Mucke L. Tau: Enabler Diverse Brain Disorders Target Rapidly Evol Therapeutic Strategies Sci. 2021;371(6532).","DOI":"10.1126\/science.abb8255"},{"issue":"5","key":"844_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2020.09.029","volume":"108","author":"JW Lewcock","year":"2020","unstructured":"Lewcock JW, et al. Emerging microglia biology defines novel therapeutic approaches for Alzheimer\u2019s disease. Neuron. 2020;108(5):801\u201321.","journal-title":"Neuron"},{"issue":"5","key":"844_CR9","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1021\/jm201468j","volume":"55","author":"HC Shen","year":"2012","unstructured":"Shen HC, Hammock BD. Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications. J Med Chem. 2012;55(5):1789\u2013808.","journal-title":"J Med Chem"},{"issue":"5431","key":"844_CR10","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","volume":"285","author":"K Node","year":"1999","unstructured":"Node K, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999;285(5431):1276\u20139.","journal-title":"Science"},{"issue":"19","key":"844_CR11","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1021\/jm100691c","volume":"53","author":"TE Rose","year":"2010","unstructured":"Rose TE, et al. 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain. J Med Chem. 2010;53(19):7067\u201375.","journal-title":"J Med Chem"},{"issue":"2","key":"844_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.gene.2013.05.008","volume":"526","author":"TR Harris","year":"2013","unstructured":"Harris TR, Hammock BD. Soluble epoxide hydrolase: gene structure, expression and deletion. Gene. 2013;526(2):61\u201374.","journal-title":"Gene"},{"issue":"1","key":"844_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41514-022-00090-1","volume":"8","author":"CM Davis","year":"2022","unstructured":"Davis CM, et al. Age-dependent cognitive impairment, hydrocephalus and leukocyte infiltration in Transgenic mice with endothelial expression of human EPHX2. NPJ Aging. 2022;8(1):9.","journal-title":"NPJ Aging"},{"issue":"13","key":"844_CR14","doi-asserted-by":"publisher","first-page":"E1944","DOI":"10.1073\/pnas.1601532113","volume":"113","author":"Q Ren","year":"2016","unstructured":"Ren Q, et al. Gene deficiency and Pharmacological Inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress. Proc Natl Acad Sci U S A. 2016;113(13):E1944\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"844_CR15","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1073\/pnas.1819234116","volume":"116","author":"M Ma","year":"2019","unstructured":"Ma M, et al. Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation. Proc Natl Acad Sci U S A. 2019;116(14):7083\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"844_CR16","doi-asserted-by":"publisher","first-page":"E5815","DOI":"10.1073\/pnas.1802179115","volume":"115","author":"Q Ren","year":"2018","unstructured":"Ren Q, et al. Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2018;115(25):E5815\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"844_CR17","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1093\/hmg\/ddx329","volume":"26","author":"B Padhy","year":"2017","unstructured":"Padhy B, et al. Pseudoexfoliation and Alzheimer\u2019s associated CLU risk variant, rs2279590, Lies within an enhancer element and regulates CLU, EPHX2 and PTK2B gene expression. Hum Mol Genet. 2017;26(22):4519\u201329.","journal-title":"Hum Mol Genet"},{"key":"844_CR18","doi-asserted-by":"publisher","first-page":"147096","DOI":"10.1016\/j.gene.2022.147096","volume":"854","author":"B Padhy","year":"2023","unstructured":"Padhy B, et al. Wide-spread enhancer effect of SNP rs2279590 on regulating epoxide hydrolase-2 and protein tyrosine kinase 2-beta gene expression. Gene. 2023;854:147096.","journal-title":"Gene"},{"issue":"10","key":"844_CR19","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1038\/s41380-021-01251-6","volume":"26","author":"YN Ou","year":"2021","unstructured":"Ou YN, et al. Identification of novel drug targets for Alzheimer\u2019s disease by integrating genetics and proteomes from brain and blood. Mol Psychiatry. 2021;26(10):6065\u201373.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"844_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo AP, et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat Genet. 2021;53(2):143\u20136.","journal-title":"Nat Genet"},{"issue":"1","key":"844_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13195-021-00893-6","volume":"13","author":"K Borkowski","year":"2021","unstructured":"Borkowski K, et al. Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13(1):149.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"844_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13195-022-01084-7","volume":"14","author":"B Ebright","year":"2022","unstructured":"Ebright B, et al. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer\u2019s dementia. Alzheimers Res Ther. 2022;14(1):152.","journal-title":"Alzheimers Res Ther"},{"key":"844_CR23","doi-asserted-by":"crossref","unstructured":"Ghosh A et al. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2020;12(573).","DOI":"10.1126\/scitranslmed.abb1206"},{"issue":"42","key":"844_CR24","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1523\/JNEUROSCI.1246-20.2020","volume":"40","author":"W Chen","year":"2020","unstructured":"Chen W, et al. 14,15-Epoxyeicosatrienoic acid alleviates pathology in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2020;40(42):8188\u2013203.","journal-title":"J Neurosci"},{"issue":"18","key":"844_CR25","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","volume":"111","author":"Y Wu","year":"2023","unstructured":"Wu Y, et al. Hepatic soluble epoxide hydrolase activity regulates cerebral Abeta metabolism and the pathogenesis of Alzheimer\u2019s disease in mice. Neuron. 2023;111(18):2847\u2013e286210.","journal-title":"Neuron"},{"key":"844_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.prostaglandins.2012.07.005","volume":"104\u2013105","author":"KI Strauss","year":"2013","unstructured":"Strauss KI, Gruzdev A, Zeldin DC. Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury. Prostaglandins Other Lipid Mediat. 2013;104\u2013105:18\u201324.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"844_CR27","doi-asserted-by":"crossref","unstructured":"Parra Bravo C et al. Human iPSC 4R Tauopathy model uncovers modifiers of Tau propagation. Cell. 2024.","DOI":"10.1101\/2023.06.19.544278"},{"issue":"6","key":"844_CR28","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","volume":"100","author":"A Litvinchuk","year":"2018","unstructured":"Litvinchuk A, et al. Complement C3aR inactivation attenuates Tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer\u2019s disease. Neuron. 2018;100(6):1337\u2013e13535.","journal-title":"Neuron"},{"issue":"11","key":"844_CR29","doi-asserted-by":"publisher","first-page":"e80706","DOI":"10.1371\/journal.pone.0080706","volume":"8","author":"Q Guo","year":"2013","unstructured":"Guo Q, et al. Modeling Alzheimer\u2019s disease in mouse without mutant protein overexpression: cooperative and independent effects of Abeta and Tau. PLoS ONE. 2013;8(11):e80706.","journal-title":"PLoS ONE"},{"issue":"9","key":"844_CR30","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.15252\/emmm.201303671","volume":"6","author":"VA Polito","year":"2014","unstructured":"Polito VA, et al. Selective clearance of aberrant Tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med. 2014;6(9):1142\u201360.","journal-title":"EMBO Mol Med"},{"key":"844_CR31","doi-asserted-by":"crossref","unstructured":"Wang B et al. TFEB-vacuolar ATPase signaling regulates lysosomal function and microglial activation in tauopathy. Nat Neurosci. 2023.","DOI":"10.1101\/2023.02.06.527293"},{"issue":"9","key":"844_CR32","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41592-023-01943-7","volume":"20","author":"SJ Fleming","year":"2023","unstructured":"Fleming SJ, et al. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using cellbender. Nat Methods. 2023;20(9):1323\u201335.","journal-title":"Nat Methods"},{"issue":"4","key":"844_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock SL, Lopez R, Klein AM. Scrublet: computational identification of cell doublets in Single-Cell transcriptomic data. Cell Syst. 2019;8(4):281\u2013e2919.","journal-title":"Cell Syst"},{"issue":"1","key":"844_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19(1):15.","journal-title":"Genome Biol"},{"issue":"1","key":"844_CR35","doi-asserted-by":"publisher","first-page":"e9620","DOI":"10.15252\/msb.20209620","volume":"17","author":"C Xu","year":"2021","unstructured":"Xu C, et al. Probabilistic harmonization and annotation of single-cell transcriptomics data with deep generative models. Mol Syst Biol. 2021;17(1):e9620.","journal-title":"Mol Syst Biol"},{"issue":"7719","key":"844_CR36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno G, et al. RNA velocity of single cells. Nature. 2018;560(7719):494\u20138.","journal-title":"Nature"},{"issue":"12","key":"844_CR37","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen V, et al. Generalizing RNA velocity to transient cell States through dynamical modeling. Nat Biotechnol. 2020;38(12):1408\u201314.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"844_CR38","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1084\/jem.20172158","volume":"215","author":"H Martini-Stoica","year":"2018","unstructured":"Martini-Stoica H, et al. TFEB enhances astroglial uptake of extracellular Tau species and reduces Tau spreading. J Exp Med. 2018;215(9):2355\u201377.","journal-title":"J Exp Med"},{"key":"844_CR39","doi-asserted-by":"crossref","unstructured":"Gedam M et al. Complement C3aR depletion reverses HIF-1alpha-induced metabolic impairment and enhances microglial response to Abeta pathology. J Clin Invest. 2023;133(12).","DOI":"10.1172\/JCI167501"},{"issue":"4","key":"844_CR40","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy ER, et al. Type I interferon response drives neuroinflammation and synapse loss in alzheimer disease. J Clin Invest. 2020;130(4):1912\u201330.","journal-title":"J Clin Invest"},{"key":"844_CR41","doi-asserted-by":"crossref","unstructured":"Kuljis DA et al. Fluorescence-Based quantitative synapse analysis for cell Type-Specific connectomics. eNeuro. 2019;6(5).","DOI":"10.1523\/ENEURO.0193-19.2019"},{"issue":"19","key":"844_CR42","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost B, Jacks RL, Diamond MI. Propagation of Tau misfolding from the outside to the inside of a cell. J Biol Chem. 2009;284(19):12845\u201352.","journal-title":"J Biol Chem"},{"issue":"17","key":"844_CR43","doi-asserted-by":"publisher","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","volume":"286","author":"JL Guo","year":"2011","unstructured":"Guo JL, Lee VM. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem. 2011;286(17):15317\u201331.","journal-title":"J Biol Chem"},{"issue":"7","key":"844_CR44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, et al. Transmission and spreading of tauopathy in Transgenic mouse brain. Nat Cell Biol. 2009;11(7):909\u201313.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"844_CR45","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba M, et al. Synthetic Tau fibrils mediate transmission of neurofibrillary tangles in a Transgenic mouse model of Alzheimer\u2019s-like Tauopathy. J Neurosci. 2013;33(3):1024\u201337.","journal-title":"J Neurosci"},{"issue":"4","key":"844_CR46","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s12035-018-1261-z","volume":"56","author":"HT Lee","year":"2019","unstructured":"Lee HT, et al. Genetic deletion of soluble epoxide hydroxylase causes Anxiety-Like behaviors in mice. Mol Neurobiol. 2019;56(4):2495\u2013507.","journal-title":"Mol Neurobiol"},{"key":"844_CR47","doi-asserted-by":"crossref","unstructured":"Grinan-Ferre C et al. Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer\u2019s Disease. Neurotherapeutics. 2020.","DOI":"10.1007\/s13311-020-00854-1"},{"issue":"13","key":"844_CR48","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1016\/j.celrep.2020.03.012","volume":"30","author":"MB Chen","year":"2020","unstructured":"Chen MB, et al. Brain endothelial cells are exquisite sensors of Age-Related circulatory cues. Cell Rep. 2020;30(13):4418\u2013e44324.","journal-title":"Cell Rep"},{"issue":"1","key":"844_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","volume":"99","author":"A Ittner","year":"2018","unstructured":"Ittner A, Ittner LM. Dendritic Tau in Alzheimer\u2019s disease. Neuron. 2018;99(1):13\u201327.","journal-title":"Neuron"},{"issue":"1","key":"844_CR50","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1038\/s41467-023-42295-2","volume":"14","author":"Z Shen","year":"2023","unstructured":"Shen Z, et al. Multivalent Tau\/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density. Nat Commun. 2023;14(1):6839.","journal-title":"Nat Commun"},{"issue":"1","key":"844_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-016-0109-0","volume":"11","author":"PD Sohn","year":"2016","unstructured":"Sohn PD, et al. Acetylated Tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment. Mol Neurodegener. 2016;11(1):47.","journal-title":"Mol Neurodegener"},{"key":"844_CR52","doi-asserted-by":"crossref","unstructured":"Xu Y et al. Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading. Proc Natl Acad Sci U S A. 2021;118(27).","DOI":"10.1073\/pnas.2023418118"},{"issue":"9","key":"844_CR53","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1021\/acschemneuro.9b00271","volume":"10","author":"Z Liang","year":"2019","unstructured":"Liang Z, et al. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a selective and potent dual inhibitor of soluble epoxide hydrolase and p38 kinase intervenes in Alzheimer\u2019s signaling in human nerve cells. ACS Chem Neurosci. 2019;10(9):4018\u201330.","journal-title":"ACS Chem Neurosci"},{"key":"844_CR54","doi-asserted-by":"crossref","unstructured":"Dolan MJ et al. Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional States in vitro. Nat Immunol. 2023.","DOI":"10.1038\/s41590-023-01558-2"},{"issue":"5","key":"844_CR55","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41593-023-01315-6","volume":"26","author":"JC Udeochu","year":"2023","unstructured":"Udeochu JC, et al. Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience. Nat Neurosci. 2023;26(5):737\u201350.","journal-title":"Nat Neurosci"},{"issue":"7684","key":"844_CR56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature25013","volume":"552","author":"J Hu","year":"2017","unstructured":"Hu J, et al. Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy. Nature. 2017;552(7684):248\u201352.","journal-title":"Nature"},{"issue":"10","key":"844_CR57","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1016\/j.celrep.2019.11.006","volume":"29","author":"XH Qin","year":"2019","unstructured":"Qin XH, et al. Liver soluble epoxide hydrolase regulates behavioral and cellular effects of chronic stress. Cell Rep. 2019;29(10):3223\u2013e32346.","journal-title":"Cell Rep"},{"key":"844_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pneurobio.2018.11.001","volume":"172","author":"S Zarriello","year":"2019","unstructured":"Zarriello S, et al. Humble beginnings with big goals: small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders. Prog Neurobiol. 2019;172:23\u201339.","journal-title":"Prog Neurobiol"},{"issue":"5","key":"844_CR59","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/j.1476-5381.2011.01641.x","volume":"165","author":"A Ulu","year":"2012","unstructured":"Ulu A, et al. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys. Br J Pharmacol. 2012;165(5):1401\u201312.","journal-title":"Br J Pharmacol"},{"issue":"16","key":"844_CR60","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1021\/jm500694p","volume":"57","author":"KS Lee","year":"2014","unstructured":"Lee KS, et al. Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy. J Med Chem. 2014;57(16):7016\u201330.","journal-title":"J Med Chem"},{"issue":"4","key":"844_CR61","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1021\/acs.jmedchem.0c01886","volume":"64","author":"BD Hammock","year":"2021","unstructured":"Hammock BD, et al. Movement to the clinic of soluble epoxide hydrolase inhibitor EC5026 as an analgesic for neuropathic pain and for use as a nonaddictive opioid alternative. J Med Chem. 2021;64(4):1856\u201372.","journal-title":"J Med Chem"},{"issue":"10","key":"844_CR62","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1007\/s00259-021-05231-4","volume":"48","author":"JM Coughlin","year":"2021","unstructured":"Coughlin JM, et al. First-in-human neuroimaging of soluble epoxide hydrolase using [(18)F]FNDP PET. Eur J Nucl Med Mol Imaging. 2021;48(10):3122\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00844-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00844-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00844-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T22:02:57Z","timestamp":1745359377000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00844-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["844"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00844-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6038641\/v1","asserted-by":"object"}]},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"15 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were performed in accordance with NIH guidelines and with the approval of the Baylor College of Medicine Institutional Animal Care and Use Committee prior to all animal-related studies (IACUC protocol # AN-1853).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the contents of this manuscript and provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}